Live feed
Filing
SC 13D
SC 13D0001477932-23-005629·AEON Biopharma, Inc.
Schedule 13D ownership disclosure
AEON Biopharma, Inc.
Security class unavailable · CUSIP: 00791X100
Event date: 2023-07-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 25.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001477932-23-005629
- Form type
- SC 13D
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Jul 31, 2023
- Reporting period
- Jul 21, 2023
- Description
- Schedule 13D beneficial ownership